You are here

Listing notices

If you intend to rely on any legislation referred to on this website, you should access copies of the official versions on the Attorney-General's ComLaw website, which incorporates the Federal Register of Legislative Instruments (FRLI). Instruments are amended from time to time and may, on occasions, be replaced or new instruments made.

Medicines are registered or listed on the Australian Register of Therapeutic Goods, depending on the ingredients they contain and the therapeutic claims that are being made.

In general, products that contain low risk ingredients are referred to as listed medicines by the Therapeutic Goods Administration. Most listed medicines are considered to be of relatively low risk compared to other types of medicines, such as prescription medicines, as they:

  • may only contain ingredients that have been approved by the TGA as being of low risk, and
  • may only make limited therapeutic claims.

In order for a medicine to be listed on the ARTG, it needs to be either

  • included in Schedule 4 of the Therapeutic Goods Regulations 1990; or
  • listed after the publication of a relevant Therapeutic Goods Listing Notice.

Therapeutic Goods Listing Notices specify particular ingredients that can be used as therapeutically active ingredients in listed products. These notices are approved by a delegate of the Minister under section 9 of the Therapeutic Goods Act 1989. When considered necessary, an advisory committee is consulted before approval.

  • 8 November 2000
    Listing notice - oil derived from the root or stem wood of the species Santalum spicatum, oil derived from the leaf of the species Backhousia citriodora
  • 14 August 2000
    Listing notice - tocotrienols complex - palm
  • 20 April 2000
    Listing notice - chondroitin sulfate - bovine, chondroitin sulfate - shark, papain
  • 6 March 2000
    Listing notice - lactoferrin - bovine, colloidal anhydrous silica or silicon dioxide, glucosamine sulfate-potassium chloride complex or glucosamine sulfatesodium chloride complex, R,S- or R-alpha lipoic acid, levocarnitine, acctyllevocarnitine hydrochloride, propionyllcvocarnitine hydrochloride, levocarnitine hydrochloride, levocarnitine tartrate, levocarnitine fumarate or levocarnitine magnesium citrate, bromclain, lecithin, soy -soy phosphatidylserine-enriched